Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CDK14 polyclonal antibody

Product Specifications

Background

PFTK1 is a member of the CDC2 (MIM 116940) -related protein kinase family (Yang and Chen, 2001 [PubMed 11313143]) .[supplied by OMIM, Mar 2008]

CAS Number

9007-83-4

Structure Composition

1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Product Name Alternative

CDK14; PFTAIRE1; PFTK1

Swiss Prot

O94921

Reactivity

Human

Immunogen

Recombinant fusion protein of human CDK14 (NP_036527.1) .

Conjugation

Unconjugated

Applications

WB, IHC

Dilution

WB,1:500 - 1:1000|IHC,1:50 - 1:100

Purity

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Modification

Unmodification

Molecular Weight

45kDa

Storage Conditions

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Notes

For research use only, not for use in diagnostic procedure.

Specificity

Unmodification

Host or Source

Rabbit

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Fluor700 Anti-Human CD123 Antibody [6H6]
MBS2579503-01 20 Tests

Fluor700 Anti-Human CD123 Antibody [6H6]

Ask
View Details
Fluor700 Anti-Human CD123 Antibody [6H6]
MBS2579503-02 100 Tests

Fluor700 Anti-Human CD123 Antibody [6H6]

Ask
View Details
Fluor700 Anti-Human CD123 Antibody [6H6]
MBS2579503-03 2x 100 Tests

Fluor700 Anti-Human CD123 Antibody [6H6]

Ask
View Details
Fluor700 Anti-Human CD123 Antibody [6H6]
MBS2579503-04 10x 100 Tests

Fluor700 Anti-Human CD123 Antibody [6H6]

Ask
View Details
Anti-IGF1R/CD221 Reference Antibody (robatumumab)
MBS9247163-01 0.1 mg

Anti-IGF1R/CD221 Reference Antibody (robatumumab)

Ask
View Details
Anti-IGF1R/CD221 Reference Antibody (robatumumab)
MBS9247163-02 5x 0.1 mg

Anti-IGF1R/CD221 Reference Antibody (robatumumab)

Ask
View Details